State University of New York

State University of New York

State University of New York

Date Founded




Charitable Causes

Education Research & Support


Schools & Student Services

Company Description

The State University of New York is the largest comprehensive university system in the United States, educating approximately 468,000 students in more than 7,500 degree and certificate programs, and more than 1.8 million NYS citizens in professional development and personal enrichment programs, on 64 college and university campuses. There are nearly 3 million SUNY alumni worldwide.

Contact Data
Trying to get in touch with decision makers at State University of New York? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Vice Chancellor for Finance & Chief Financial Officer

Deputy Chief of Staff for Policy

Director of the Office for Capital Facilities

General Counsel, Charter Schools Institute

Senior Vice Chancellor for Legal Affairs & General Counsel

Executive Vice Chancellor for Academic Affairs & Provost

Deputy General Counsel

Vice Provost for Academic Planning & Strategic Leadership & Senior Associate Vice Chancellor

Vice Provost & Vice Chancellor, Academic Affairs

Chief Information Officer

Board of Directors

Director at PTS Intermediate Holdings LLC

Distinguished Alumni
David S. Graziosi is now Director, President & Chief Executive Officer at Allison Transmission Holdings, Inc.
Donald M. Kendall, Sr. is now Co-Founder at PepsiCo, Inc.
Paths to State University of New York
Potential Connections via
Relationship Science
State University of New York
Advisors & Consultants

Chairman at Lipman Hearne, Inc.


Managing Director & Principal at CCS Fundraising


Assistant Vice Chancellor for External Affairs at State University of New York


PeptiDream Inc. engages in the biopharmaceutical business that includes research and development of non standard peptide therapeutics. It produces stable, and potent non-standard macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by State University of New York. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of State University of New York's profile does not indicate a business or promotional relationship of any kind between RelSci and State University of New York.